New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma

Bcl-2 family members: Dual regulators of apoptosis and autophagy

(2014) Beth Levine et al.   Autophagy

New developments in Toll-like receptor targeted therapeutics

(2012) Dympna J Connolly et al.   CURRENT OPINION IN PHARMACOLOGY

Propranolol Use in PHACE Syndrome with Cervical and Intracranial Arterial Anomalies: Collective Experience in 32 Infants

(2012) Denise Metry et al.   PEDIATRIC DERMATOLOGY

TLR2 Controls Intestinal Carcinogen Detoxication by CYP1A1

(2012) Khoa Nguyen Do et al.   PLoS One

Multiple myeloma: biology of the disease

(2010) Anuj Mahindra et al.   BLOOD REVIEWS

Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action

(2010) C.H. Storch et al.   BRITISH JOURNAL OF DERMATOLOGY

Chemosensitization of Prostate Cancer by Modulating Bcl-2 Family Proteins

(2010) David Karnak et al.   CURRENT DRUG TARGETS

Update on vascular tumors of infancy

(2010) Robert Sidbury   CURRENT OPINION IN PEDIATRICS

Effect of beta blocker combined with COX-2 inhibitor on colonic anastomosis in rats

(2010) Barak Benjamin et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Improving Survival Rates in Two Models of Spontaneous Postoperative Metastasis in Mice by Combined Administration of a β-Adrenergic Antagonist and a Cyclooxygenase-2 Inhibitor

(2010) Ariella Glasner et al.   JOURNAL OF IMMUNOLOGY

Propranolol for infantile hemangiomas: Early experience at a tertiary vascular anomalies center

(2010) Lisa M. Buckmiller et al.   LARYNGOSCOPE

Response of infantile hepatic hemangioma to propranolol resistant to high-dose methylprednisolone and interferon-α therapy

(2010) Faik Sarialioglu et al.   PEDIATRIC BLOOD & CANCER

Propranolol for Severe Infantile Hemangiomas: Follow-Up Report

(2009) V. Sans et al.   PEDIATRICS

Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion

(2009) Borhane Annabi et al.   PHARMACOLOGICAL RESEARCH

Perioperative Use of β-blockers and COX-2 Inhibitors May Improve Immune Competence and Reduce the Risk of Tumor Metastasis

(2008) Marganit Benish et al.   ANNALS OF SURGICAL ONCOLOGY

Propranolol for Severe Hemangiomas of Infancy

(2008) Christine Léauté-Labrèze et al.   NEW ENGLAND JOURNAL OF MEDICINE